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Abstract Matrix metalloproteases (MMPs) comprise a
family of endopeptidases that are involved in remodel-
ing the extracellular matrix and play a critical role in
learning and memory. At least 24 different MMP sub-
types have been identified in the human brain, but less
is known about the subtype-specific actions of MMP on
neuronal plasticity. The long-term potentiation (LTP) of
excitatory synaptic transmission and scaling of dendritic
and somatic neuronal excitability are considered sub-
strates of memory storage. We previously found that
MMP-3 and MMP-2/9 may be differentially involved
in shaping the induction and expression of excitatory
postsynaptic potential (EPSP)-to-spike (E-S) potentiation
in hippocampal brain slices. MMP-3 and MMP-2/9 pro-
teolysis was previously shown to affect the integrity or
mobility of synaptic N-methyl-D-aspartate receptors
(NMDARs) in vitro. However, the functional outcome
of such MMP-NMDAR interactions remains largely un-
known. The present study investigated the role of these
MMP subtypes in E-S plasticity and NMDAR function
in mouse hippocampal acute brain slices. The temporal
requirement for MMP-3/NMDAR activity in E-S poten-
tiation within the CA1 field largely overlapped, and
MMP-3 but not MMP-2/9 activity was crucial for the
gain-of-function of NMDARs following LTP induction.
Functional changes in E-S plasticity following MMP-3
inhibition largely correlated with the expression of cFos
protein, a marker of activity-related gene transcription.
Recombinant MMP-3 promoted a gain in NMDAR-
mediated field potentials and somatodendritic Ca2+
waves. These results suggest that long-term hippocampal
E-S potentiation requires transient MMP-3 activity that
promotes NMDAR-mediated postsynaptic Ca2+ entry
that is vital for the activation of downstream signaling
cascades and gene transcription.
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Introduction
In the central nervous system, several forms of experience-
dependent plasticity (i.e., substrates of learning and memory)
require the activity-dependent control of synaptic efficacy. In
a classic (although not unique) mechanism,N-methyl-D-aspar-
tate receptors (NMDARs) gate Ca2+ influx following mem-
brane depolarization during episodes of neuronal activity and
determine the extent of synaptic long-term potentiation (LTP)
or long-term depression (LTD) that subsequently develops [1].
α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid re-
ceptors (AMPARs) mediate the majority of synaptic currents
at excitatory synapses. Most studies on the mechanisms of
excitatory synapses have focused on changes in AMPAR-
mediated signals. However, the NMDAR-mediated compo-
nent may reveal various forms of plasticity and directly or
indirectly influence neuroplastic changes at different levels
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of neuronal processing. For example, impairments in long-
term associative memory that are induced by blocking
NMDARs after behavioral training [2] clearly demonstrate
that the role of these receptors goes well beyond their
well-established function in LTPAMPA induction.
Moreover, the number and/or subunit composition of
synaptic NMDARs may be regulated by neuronal activ-
ity and sensory experience [3], and the plasticity of the
NMDAR component might subsequently influence the
plasticity of the AMPAR component [4]. Additionally,
in an intact acute brain slice preparation, the NMDAR
component of field excitatory postsynaptic potentials
(fEPSPs) in response to low-frequency stimulation was
barely detectable, or other conductances (e.g., γ-
aminobutyric acid [GABA]ergic transmission and out-
ward potassium currents) may mask NMDAR-related
synaptic currents [5, 6]. However, no systematic studies
have evaluated the temporal effect of NMDARs on hip-
pocampal plasticity. In addition to synaptic plasticity,
memory storage may involve multiple levels of long-
term modifications of neuronal input-output properties
through far more complex mechanisms than LTP-
LTDAMPA alone. Neurons can significantly enhance in-
formation storage capacity by scaling dendritic and so-
matic excitability and learning [7, 8]. A hallmark of
such a phenomenon occurs during tetanically evoked
synaptic LTP when the probability of firing an action
potential in postsynaptic neurons increases beyond the
probability that is predicted by an increase in synaptic
input (excitatory postsynaptic potential (EPSP)-to-spike
potentiation; E-S plasticity [9, 10]). Although synaptic
and nonsynaptic plasticity differs in the mechanism of
expression, these processes share the common require-
ments of NMDAR activation and rise in postsynaptic
Ca2+. However, the temporal requirement for NMDAR
activity in synaptic LTPAMPA and E-S potentiation re-
mains unknown.
Enhancements in neuronal activity are associated with
the release of specific factors that further support the
maintenance of synaptic plasticity. The activity of extra-
cellular matrix metalloproteases (MMP), a family of
zinc endopeptidases, was shown to play a crucial role
in learning and memory [11, 12]. To date, at least 24
MMP subtypes have been identified in the brain, includ-
ing secreted and membrane-bound subtypes, and dozens
of MMP substrates have been identified in vitro [11].
However, remaining largely unknown is the cellular
mechanism of such MMP subtype-specific proteolysis
in hippocampal plasticity. The best characterized
MMPs in neurons and glia are gelatinases MMP-2 and
MMP-9. MMP-9 was shown to affect long-term synap-
tic plasticity and memory consolidation [11, 13]. More
recent data showed that stromelysin MMP-3 was
upregulated in the hippocampus following learning and
supported hippocampal synaptic plasticity [14–16]. In
addition to modulating synaptic plasticity, a recent study
found that acute and long-term extracellular proteolysis
affected long-term neuronal excitability [10]. We recent-
ly found that the activity of certain MMP subtypes may
modulate long-term NMDAR function, and MMP-3 and
MMP-2/9 inhibition differentially affected the time
course of E-S potentiation [17]. In the present study,
we investigated the temporal relationships between the
activity of these MMP subtypes, NMDAR function, and
E-S potentiation in the CA1 region of the hippocampus.
We found that the temporal requirement for NMDAR
and MMP activity with regard to the expression of E-
S potentiation largely overlapped and was still detect-
able approximately 15-30 min post tetanic stimulation.
We also found that synaptic NMDAR function and post-
synaptic Ca2+ entry were specifically regulated by
MMP-3. Moreover, the magnitude of E-S potentiation
following MMP-3 or NMDAR inhibition largely corre-
lated with the expression of the nuclear protein cFos in
CA1 pyramidal neurons, a marker of activity-related
gene transcription. Altogether, we propose that MMP-3
activity may support long-term hippocampal E-S plastic-
ity by promoting NMDAR-related postsynaptic Ca2+ en-
try and downstream intracellular cascades that are in-
volved in activity-regulated gene expression. These re-
sults provide insights into the cellular mechanism of
action of MMP on hippocampal plasticity that may open
new lines of investigation on the rapid modulation of
ionotropic synaptic NMDARs and Ca2+ entry by extra-
cellular MMP.
Materials and Methods
Acute Brain Slice Electrophysiology
The electrophysiological studies were conducted with
C57BL/6 mice 30–60 days after birth. Acute brain
slices were prepared as described previously [17]. All
of the experimental procedures were approved by the
Local Ethics Committee. Recordings were made in arti-
ficial cerebrospinal fluid (aCSF) that consisted of the
following: 125 mM NaCl, 25 mM NaHCO3, 2.6 mM
KCl, 1.25 mM NaH2PO4, 2.5 mM CaCl2, and 20 mM
glucose, pH 7.4, at a temperature of 31 °C. Schaffer
collateral (SCH) axons were stimulated with a concen-
tric bipolar electrode (0.1 Hz, 0.25 ms). fEPSPs were
recorded with glass micropipettes that were filled with
aCSF (1-3 MΩ resistance) in the stratum radiatum of
the CA1 region (150–200 μm from the stratum
pyramidale). Population spikes were simultaneously
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recorded with another electrode that was placed in the
stratum pyramidale below on the same axis (Fig. 1a).
NMDAR-mediated signals were isolated with the
AMPA/kainate receptor antagonist DNQX (20 μM) and
L-type calcium channel blocker nifedipine (20 μM) in
Mg2+-free solutions, as described previously [17]. At the
end of each recording, the NMDAR antagonist APV
(50 μM) was used to confirm the origin of the recorded
fEPSPNMDA. We used the following MMP inhibitors:
MMP-3 inhibitors NNGH (10 μM) and UK356618
(2 μM) and MMP-2/9 inhibitor SB3CT (10 μM). All
of the drugs were obtained from Sigma-Aldrich
(Poland), Tocris (UK), and Merck/Calbiochem (USA).
Linear pept ide GRGDSP was purchased f rom
Proteogenix (France). The electrophysiology data were
analyzed using pClamp10.3 software (Molecular
Devices, USA) and AxoGraphX software (developed
by John Clements) as described previously [17].
Immunofluorescence in Hippocampal Sections
Immediately after the electrophysiological recordings, the hip-
pocampal slices were fixed in 4 % paraformaldehyde for
1 day, washed in phosphate-buffered saline (PBS), and cut
into 40-μm-thick sections on a vibratome (LeicaVT1000S)
in gelatin blocks that were held at 4 °C. The sections were
incubated overnight with primary antibodies (anti-c-Fos anti-
body, sc-7202, 1:200, Santa Cruz Biotechnology, Santa Cruz,
CA, USA; anti-NeuN antibody, 1:1000, MAB377, Millipore,
USA) and 3 % normal horse serum (NHS) at 4 °C. The slices
were then washed in PBS with 0.3 % Triton X-100 and incu-
bated with secondary antibodies conjugated with
AlexaFLuor488 or AlexaFluor633 (ThermoFisher Scientific,
Molecular Probes, USA). The sections were visualized with a
FluoView1000 confocal microscope (Olympus, Poland) with
a dry ×40/0.95NA objective. For a given slice, cFos + neurons
were analyzed as described previously [18] in three non-
overlapping three-dimensional pictures of the CA1 area
downstream of the stimulation electrode.
Calcium Imaging in Hippocampal Neuronal Cultures
Hippocampal neuronal cultures were prepared as described
previously [19]. Neurons (cultured 14 days in vitro) were in-
cubated for 30 min with Fura2 acetoxymethyl ester (2 μM,
ThermoFisher Scientific, Molecular Probes, USA). The cells
were then extensively washed with Ringer solution that
consisted of the following: 137 mM NaCl, 5 mM KCl,
2 mM CaCl2, 1 mM MgCl2, 20 mM glucose, and 10 mM
HEPES (pH 7.3). Recordings were made in Ringer solution
in a microscope environmental chamber at 37 °C. Changes in
intracellular calcium levels were measured using a Leica
AF7000 Live Imaging System (Leica Microsystems GmbH,
Wetzlar, Germany) with a ×20/0.7NA objective. Pairs of
background-subtracted intensity images (16 bit, 502 ×
501 pixels) were captured every 5 s at 510 nm (340 and
380 nm excitation wavelengths). To record Ca2+ waves that
were associated solely with NMDARs, the recording solution
was supplemented with the sodium channel blocker tetrodo-
toxin (1 μM), GABAA receptor blocker picrotoxin (10 μM),
AMPA/kainate receptor blocker DNQX (10 μM), L-type cal-
cium channel blocker nifedipine (10 μM), and NMDAR co-
agonists D-serine and glycine (1 μM). NMDA (60 μM) was
applied for 60 s, and the sections were then extensively
washed until the ΔF340/F380 signal returned to baseline (typ-
ically 5 min). To discriminate neurons from astrocytes, KCl
(60 mM) was applied at the end of Fura2 imaging. Rapid shift
in resting membrane potential toward depolarization and Ca2+
wave is observed in these conditions primarily in neurons
rather than astrocytes [20]. Recombinant human MMP-3
(MBS142425, MyBioSource, Belgium) was activated accord-
ing to the manufacturer’s instructions and tested for specific
activity with a fluorogenic peptide substrate (ES002, R&D
Systems, USA) and fluorescence plate reader (EnSpire
Multimode Plate Reader, PerkinElmer, USA).
Glutamate-Evoked Field Potential Recordings
Recordings of glutamate-evoked NMDAR-mediated field po-
tentials were performed in acute brain slices in two steps. We
first pharmacologically isolated NMDAR-mediated signals as
described previously [17] (Fig. 2). After confirming the oc-
currence of synaptic NMDAR responses in the CA1 stratum
radiatum, a field-potential recording pipette was approached
with patch pipette (4-6 MΩ tip resistance) that was filled with
glutamate (1 mM) and the synaptic NMDAR co-agonist D-
serine (100 μM; Fig. 4a). Field potentials were recorded in
response to short (200 ms) local application of the pipette
solution via the Picospritzer®III system (Parker-Hannifin,
USA; 6 PSI valve pressure).
Image analysis was performed using Fiji software [21]. The
statistical analysis was performed using Student’s t test and
analysis of variance (ANOVA), followed by post hoc tests or
χ2 tests as appropriate. The analyses were performed using
SigmaStat 3.1 software (Systat Software). The data are
expressed as mean ± SEM. The level of significance was p <
0.05.
Results
NMDAR Activity Supports E-S Plasticity Beyond
an Episode of Enhanced Synaptic Activity
We first studied the temporal requirement for NMDAR activ-
ity in long-term E-S potentiation in the CA1 region of the
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hippocampus. We stimulated the SCH and recorded fEPSPs
and population spikes (PSs) in the CA1 strata radiatum and
pyramidale (Fig. 1a). Following basal stimulation (0.1 Hz,
15 min), we applied tetanic high-frequency stimulation
(HFS; 4 × 100 Hz, 1 s, repeated every 10 s) and monitored
the signals for the next 90 min. In control slices, HFS signif-
icantly potentiated synaptic fEPSPs and caused even more
pronounced enhancement of the PS amplitude (n = 7 slices;
p < 0.01 vs. baseline signals before HFS, Fig. 1b). Thus, the
PS/fEPSP ratio, a measure of E-S potentiation, was 3.57
± 0.24 (n = 7; p < 0.001 vs. baseline PS/fEPSP ratio, Fig. 1c).
We next bath-applied the competitive NMDAR antagonist
APV (50 μM) at different time points relative to HFS. The
application of APV 15 min before HFS completely abolished
the potentiation of both fEPSPs and PSs and PS/fEPSP ratio
was significantly reduced compared to CTR values (n = 6,
p < 0.001, Fig. 1b, c). Surprisingly, the application of APV
15 or 30 min post-HFS (APV15 and APV30, respectively)
destabilized fEPSP potentiation and reduced it to baseline
levels, whereas E-S coupling was only partially attenuated
(n = 11; p < 0.001 vs. CTR; Fig. 1b, c). Such an effect was
not observed when APV was applied 60 min post-LTP induc-
tion (n = 5; p = 0.51 vs. CTR; Fig. 1c).
E-S coupling was then characterized over a wide range of
monotonically increasing stimuli (0-300 μA) before and
90 min after HFS. As shown in Fig. 1d, significant upregula-
tion of E-S coupling was observed in CTR slices (F1,
181 = 33.04, p < 0.001), indicating enhanced postsynaptic
spiking beyond that predicted solely by the increase in synap-
tic drive. In APV15 slices, we did not observe any statistically
significant shift in the E-S curve (F1,285 = 2.33, p = 0.128).
However, a longer gap between tetanization and APVadmin-
istration resulted in a weaker effect of APVon the potentiation
of E-S coupling, demonstrated by both APV30 and APV60
slices (F1,285 = 14.9 and F1,129 = 20, respectively; p = 0.01
and p = 0.001; Fig. 1d). Altogether, NMDAR activity was
necessary for the expression of E-S potentiation within the
time window of 15–30 min post patterned synaptic activity
in the hippocampal CA1 region.
MMPActivity Blockade Interferes with E-S Coupling
Within a Temporal Window Similar to NMDAR Activity
We recently found that E-S potentiation within the hippocam-
pal CA3 associational network critically depends on MMP
activity, and MMP-3 may play a particularly important role
in the time-course of this process [17]. However, the impact of
MMP-3 inhibition on E-S coupling in the SCH-CA1 has not
been previously studied. Therefore, we analyzed E-S potenti-
ation in the presence of the bath-applied MMP-3 inhibitor
NNGH (10 μM). Upon basal stimulation, neither fEPSPs
nor PSs were affected by NNGH (data not shown).
However, HFS-induced fEPSP slope potentiation was
abolished (n = 6; p = 0.75 vs. baseline; Fig. 1e), whereas PS
amplitude upregulation was reduced but not eliminated (n = 6;
p = 0.01 vs. baseline; Fig. 1e). Altogether, the PS/fEPSP ratio
that was measured in the presence of NNGHwas significantly
less than control conditions (p < 0.001; Fig. 1f). We then bath-
applied NNGH at same time points relative to HFS as de-
scribed above in studies of APV. NNGH application 15 min
post-HFS (NNGH15) significantly attenuated the potentiation
of E-S coupling (n = 6, p = 0.01; Fig. 1f), but this effect was
not observedwhen NNGHwas applied 30 or 60min post-LTP
induction (both n = 6; p = 0.65 and 0.87, respectively; Fig. 1f).
We then calculated the change in E-S coupling in response
to a wide range of monotonically increasing stimuli (as de-
scribed above; Fig. 1g) in NNGH and NNGH15 slices, but no
Fig. 1 Temporal dependence of hippocampal E-S potentiation on
NMDARs and MMP-3 activity. a Recording scheme. Two recording
(REC) electrodes simultaneously monitored fEPSPs and population
spikes in the CA1 region in response to Schaffer collateral stimulation
(STIM). b Left, Time-course of maximal fEPSP slopes normalized to
baseline values in control slices (black circles) and when bath-applied
with the NMDAR antagonist APV (50 μM) at varying time points
relative to HFS: before HFS (red triangles), 15 min post-HFS (green
squares), or 60 min post-HFS (blue diamonds). The top shows
exemplary traces of fEPSPs before HFS (1) and 90 min after HFS
(colors match figure legend). Scale bar = 0.5 mV, 20 ms. Right, Time-
course of population spike (PS) amplitudes normalized to baseline values
in control slices (black circles) and when bath-applied with the NMDAR
antagonist APV (50 μM) at varying time points relative to HFS: before
HFS (red triangles), 15 min post-HFS (green squares), or 60 min post-
HFS (blue diamonds). The top shows exemplary and normalized traces of
PS before HFS (1) and 90 min after HFS (colors match figure legend).
Scale bar = 0.5 mV, 10 ms. c Statistics of average PS/fEPSP ratio
presented in b at 90 min post-HFS. The asterisk indicates a significant
difference vs. slices in which HFS was applied in the absence of APV.
Notice that APV that was applied up to 30 min post-HFS (green)
significantly attenuated the PS/fEPSP upregulation following HFS. d
Impact of APV on E-S coupling before HFS (circles) and 90 min after
HFS (triangles). Relationships between stimulus strength and the PS/
fEPSP slope ratio are shown. Notice that APV that was applied up to
30 min post-HFS (yellow) significantly attenuated the PS/fEPSP
upregulation following HFS that was observed in CTR (black). e Effect
of MMP-3 inhibitor NNGH (10 μM) on E-S potentiation. Middle and
right, fEPSP slope and population spike amplitude time-course,
respectively, as in b, except instead of APV, an MMP-3 inhibitor was
applied at varying time points with regards to HFS. Left, Exemplary
traces of fEPSPs (top) and population spikes (bottom) before and
90 min after HFS in the presence of NNGH (colors match figure
legends). Scale bars as in b. f Statistics of average PS/fEPSP ratio
presented in e at 90 min post-HFS. The asterisk indicates a significant
difference vs. slices in which HFS was applied in the absence of NNGH.
Notice that NNGH that was applied up to 15 min post-HFS (green)
significantly attenuated the PS/fEPSP upregulation following HFS. g
Impact of NNGH on E-S coupling before HFS (circles) and 90 min after
HFS (triangles). Relationships between stimulus strength and the
PS/fEPSP slope ratio are shown. Notice that NNGH that was applied
up to 15 min post-HFS (green) significantly attenuated the PS/fEPSP
upregulation following HFS that was observed in CTR (black). The
zero value on the time bars represents the moment of tetanization (HFS,
4 × 100 Hz). The horizontal colored bars represent drug application. The
numbers on the graphs refer to the number of experiments. *p < 0.05
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significant shift in the E-S curve was observed (both n = 6; F1,
155 = 0.27 and 0.377, respectively; p = 0.67 and 0.54, respec-
tively). However, in NNGH30 and NNGH60 slices, a signifi-
cant E-S curve shift was observed (both n = 6; F1,155 = 6.56
and 51.63, respectively; p = 0.01 and p < 0.001, respectively;
Fig. 1g). Thus, the MMP-3 inhibitor NNGH impaired E-S
potentiation in the SCH-CA1 projection when it was applied
before and up to 15–30 min after HFS.
MMP-3 but not MMP-2/9 Activity Is Crucial
for the Potentiation of NMDAR-Mediated fEPSPs
Following LTP
Considering that E-S potentiation requires nearly overlapping
activity time windows for MMP-3 and NMDARs, we hypoth-
esized that MMP supports the function of NMDARs within
the first 30 min following HFS. To test this hypothesis, we
pharmacologically isolated synaptic NMDAR-mediated re-
sponses (fEPSPNMDA; Fig. 2(a); see BMaterials and
Methods^ section) and analyzed their sensitivity to MMP in-
hibition. Notably, from the point of NMDARs conductance
for Ca2+, the signal integral (total area) rather than point am-
plitude better describes changes in NMDAR function.
Therefore, instead of analyzing the fEPSPNMDA point ampli-
tude, we analyzed the fEPSPNMDA area. We found that
fEPSPNMDA underwent slowly developing potentiation fol-
lowing HFS (134 ± 15 % of the baseline fEPSPNMDA area
60 min post-HFS; LTPNMDA, n = 12, p = 0.02; Fig. 2(b)).
When NNGH was present throughout the recordings, the
LTD of NMDAR responses was observed following HFS
(n = 6; p < 0.001 vs. baseline; Fig. 2(b)).
We then studied the temporal aspects of LTPNMDA modu-
lation by MMP-3 and found that NNGH interfered with
LTPNMDA when it was applied 15 min post-HFS (n = 6;
p = 0.89 vs. baseline; Fig. 2(b)) but had no effect when it
was applied 30 min post-HFS (163.6 ± 18 % of baseline at
60 min, Fig. 2(b); 167.7 ± 24 % of baseline at 90 min post-
HFS, data not shown; n = 6; p = 0.02 vs. baseline).
We subsequently investigated the specificity and mecha-
nism of MMP-related fEPSPNMDA potentiation. In contrast
to the actions of NNGH, application of the MMP-2/9 inhibitor
SB3CT (10 μM) did not affect LTPNMDA (n = 6; p = 0.021;
Fig. 2(b, c)). MMP-9 supports the late phase of LTPAMPA [22].
Therefore, we prolonged the recordings of fEPSPNMDA up to
90 min in the presence of SB3CT, but no effect on NMDAR
potentiation was observed (fEPSPNMDA area potentiation was
153 ± 20 % of baseline; n = 6; p = 0.036; data not shown).
Importantly, LTPNMDA was not observed in the presence of
another MMP-3 inhibitor, UK356618 (2 μM, n = 5, p = 0.65;
Fig. 2(b, c)). In summary, the gain of function of NMDARs
following HFS depended onMMP-3 activity (within a limited
time window) rather than MMP-2/9 activity.
The MMP-mediated proteolysis of extracellular proteins
may generate peptides that interfere with the integrin signaling
Fig. 2 Synaptic NMDAR potentiation critically depends onMMP-3 and
integrin signaling but not MMP-2/9. (a) Isolation of synaptic NMDAR-
mediated fEPSPs (fEPSPNMDA). Upper, Sample traces of fEPSPs
recorded in Mg2+-free solution before (gray) and after (black)
application of the AMPA/kainate antagonist DNQX (20 μM) and L-
type channel blocker nifedipine (20 μM). Lower, fEPSPNMDA (gray)
was completely abolished upon bath application of APV (50 μM)
(black). (b1) Exemplary traces of fEPSPNMDA before HFS (1) and
90 min after HFS (colors match (b2) legend). Scale bar = 0.2 mV,
20 ms. (b2) Upper, Time-course of synaptic NMDAR-mediated fEPSP
under control conditions (black) and upon bath application of MMP-3
inhibitor before HFS (red), 15min post-HFS (green), or 30min post-HFS
(yellow). Lower, Time-course of synaptic NMDAR-mediated fEPSP
under control conditions (black) and upon bath application of drugs
before HFS: MMP-3 inhibitor UK356618 (2 μM) (magenta), MMP-2/9
inhibitor (10 μM) (cyan), or integrin-blocking peptide GRGDSP (30 min
post-HFS) (gray). The zero value on the time bars represents the moment
of tetanization (HFS, 4 × 100 Hz). The horizontal colored bars represent
drug application. (c) Statistics of effects of drugs shown in (b2) measured
60 min post-HFS. The numbers on the graphs refer to the number of
experiments. *p < 0.05
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system (reviewed in [11, 12]). To determine whether integrin
signaling is involved in LTPNMDA in our system, we incubated
slices with the integrin-interfering peptide GRGDSP
(0.5 mM) 15 min before HFS. As shown in Fig. 2(b), the prior
activation of integrins with GRGDSP prevented the HFS-
induced enhancement of fEPSPNMDA (n = 4; p = 0.76 vs.
baseline before HFS). Thus, integrin signaling in our system
may be involved in HFS-induced LTPNMDA.
MMP-3 or NMDAR Inhibition Affects c-Fos Expression
Following HFS
We hypothesized that impaired E-S potentiation and synaptic
LTPNMDA followingMMP-3 inhibitionmay result in impaired
activation of Ca2+-dependent intracellular cascades associated
with the maintenance of long-term plasticity. Immediate early
genes (IEGs), such as c-fos, and IEG-encoded transcription
factors that affect target gene expression are often analyzed
to map the activation of neurons in which the transcription of
pro-plasticity genes is likely to be initiated [23, 24]. Therefore,
we analyzed the expression of the nuclear protein cFos in CA1
neurons that were fixed immediately after cessation of the
electrophysiological recordings that are shown in Figs. 1 and 2
(see BMaterials and Methods^ section). We evaluated slices in
which the effects of APVon functional E-S plasticity were stud-
ied. As shown in Fig. 3a, b, under control conditions (i.e., basally
stimulated slices and no HFS), only a small fraction of NeuN+
cells expressed cFos (n = 6). In contrast, in slices in which E-S
potentiation was induced with HFS, a significant increase in the
cFos+/NeuN+ fraction was observed compared with basally
stimulated slices (n = 7; p < 0.001). In APV and APV15 slices,
the cFos+/NeuN+ fraction was not significantly different from
basally stimulated slices (n = 6 and 11, respectively; p = 0.947
and 0.218, respectively). However, in APV30 and APV60 slices,
the cFos+/NeuN+ ratio was not significantly different from HFS-
stimulated slices that were recorded in the absence of APV, un-
like basally stimulated slices (n = 11 and 5, respectively; both
p < 0.001; Fig. 3).
We next similarly analyzed slices in which LTPNMDA was
studied. As shown in Fig. 3c, d, under control conditions (i.e.,
basally stimulated slices and no HFS), the fraction of cFos+/
NeuN+ neurons was 0.15 ± 0.02 (n = 8). In slices in which
LTPNMDA was induced, a significant increase in the cFos
+/
NeuN+ fraction was observed compared with basally stimu-
lated slices (n = 12, p = 0.017). In NNGH and NNGH15 slices,
the cFos+/NeuN+ was not significantly different from basally
stimulated slices (both n = 6; p = 0.27 and 0.85, respectively
vs. basally stimulated slices). In contrast, in NNGH30 slices,
the cFos+/NeuN+ ratio was significantly potentiated compared
only with basal stimulation (n = 6; p = 0.003). Thus, the mag-
nitude of E-S potentiation and LTPNMDA correlated with cFos
expression in CA1 pyramidal neurons, and APV and NNGH
influenced cFos expression when these drugs were applied
before or up to 15 min post-HFS.
Recombinant MMP-3 Promotes Glutamate-Evoked
NMDAR Responses and Somatodendritic Ca2+ Waves
Following Multiple Exposures to NMDA
We next investigated the effect of recombinant MMP-3 on
NMDAR function in acute brain slices. We recorded
NMDAR-mediated local field potentials that were evoked
by pressure-injected glutamate and D-serine in the presence
of DNQX and nifedipine (see BMaterials and Methods^ sec-
tion for details; Fig. 4a). Typical glutamate-evoked field po-
tentials had an amplitude of 0.4 ± 0.1 mV (n = 6 slices) and
were sensitive to APV application (Fig. 4b), indicating an
NMDAR origin. Pressure application of the bath solution
alone did not result in a detectable field potential (Fig. 4b,
aCSF). Multiple applications of glutamate (every 2 min) for
up to 45 min, together with recombinant MMP-3 (1 μg/ml),
yielded a slowly emerging potentiation of NMDAR-mediated
field potential amplitude (1.16 ± 0.03 relative change after
45 min of recording vs. baseline recorded in the first 6 min)
compared with glutamate alone (0.96 ± 0.06, n = 6 slices,
p = 0.026; Fig. 4c).
We next investigated whether MMP-3 activity affects
NMDAR-mediated Ca2+ flux. We analyzed somatodendritic
Ca2+ waves that were evoked by the exogenous application of
NMDA in cultured hippocampal neurons with the ratiometric
indicator Fura2 (see BMaterials and Methods^ section for de-
tails; Fig. 4d, e). As shown in Fig. 4f, NMDA application
(60 μM, 60 s) significantly increased ΔF340/380 fluorescence
in the somatodendritic compartment. The average amplitude
of the first NMDA-evoked Ca2+ wave was ΔF340/380 = 0.30
± 0.02 (n = 408 neurons, n = 5 cultures). Following multiple
NMDA applications every 5–6 min, the neurons exhibited
significant potentiation (>105 %, 55.5 % of all neurons;
Fig. 4f, g), no change (95 > 105 %, 10 % of all neurons or
depression (<95 %, 33.5 % of all neurons) of NMDA-evoked
Ca2+ wave amplitudes compared with the first NMDA re-
sponse (Fig. 4g). We then incubated the cultures with recom-
binant MMP-3 protein (1 μg/ml) for 30 min prior to Fura2
imaging (see BMaterials andMethods^ section for details) and
grouped neurons based on the same criteria. This pretreatment
did not significantly change the basal Ca2+ waves that were
evoked by NMDA (first NMDA-mediated Ca2+ response,
ΔF340/F380 = 0.29 ± 0.02, n = 171 neurons, p = 0.25).
However, following multiple NMDA applications, a signifi-
cant increase was observed in the fraction of neurons that
exhibited potentiation of the Ca2+ wave amplitude (sixth vs.
first application, n = 171 neurons, n = 3 cultures, χ2 = 9.88,
p = 0.007; Fig. 4g). We next incubated neuronal cultures with
NNGH during exposures to NMDA. This treatment did not
significantly change the first NMDA-mediated Ca2+ response
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(ΔF340/F380 = 0.29 ± 0.014, n = 395 neurons, p = 0.25). In
contrast, in the presence ofNNGH, significantly fewer neurons
exhibited potentiation of the Ca2+ wave amplitude (sixth vs.
first application, n = 395 neurons, n = 4 cultures, χ2 = 11.86,
p = 0.002; Fig. 4g). Altogether, exogenous MMP-3 enhanced
somatodendritic Ca2+ waves following multiple exposures to
NMDA in vitro and dendritic glutamate-evoked NMDAR-me-
diated field potentials in acute brain slices.
Discussion
E-S potentiation occurs in vivo following certain learning par-
adigms and remains a cellular correlate of learning and mem-
ory (reviewed in [8, 25]). Although the exact cellular mecha-
nism remains poorly understood, the activity of NMDARs
appears to be particularly important in determining the mag-
nitude of E-S potentiation [26, 27]. In the present study, we
combined electrophysiology, immunocytochemistry, and
Ca2+ imaging of hippocampal neurons to further investigate
E-S plasticity’s temporal requirement for NMDARs and the
extracellular activity of MMP-3 that was previously implicat-
ed as a potential modulator of NMDAR function. In the hip-
pocampal CA1 field, long-term E-S potentiation appears to
require transient MMP-3 activity that enhances NMDAR-
mediated postsynaptic Ca2+ entry, which is vital for the acti-
vation of downstream signaling cascades and gene
transcription.
Prolonged NMDARActivity Is Necessary for Maintaining
E-S Potentiation
NMDARs fuel postsynaptic cells with Ca2+ mainly during
episodes of enhanced neuronal activity and membrane de-
polarization. The present results suggest that long-term E-S
potentiation following patterned neuronal stimulation in the
hippocampal CA1 region requires temporally overlapping
NMDAR and MMP activity. The magnitude of E-S poten-
tiation depended on NMDAR activity for as long as ∼20–
30 min post neuronal activity (Fig. 1), which is consistent
with other experimental models. For example, the surface
expression of GluN1 and GluN2A subunits increased and
peaked 30 min post-HFS [28]. NMDAR activation was
also shown to support synaptic LTP within the 30 min
time window after induction in neurons in the developing
visual system in Xenopus laevis [29]. In vivo, following
learning in a passive avoidance task in chickens, an in-
crease in NMDA binding to brain synaptosomal
Fig. 3 MMP-3 or NMDAR inhibition affects c-Fos expression following
patterned neuronal activity. a Exemplary confocal immunofluorescence
images of CA1 hippocampal region (×40 magnification) in acute brain
slices fixed immediately following cessation of the electrophysiological
recordings. Basally stimulated slices (0.1 Hz) (upper panels) were
compared with slices fixed 90 min post-E-S potentiation induction in
the absence (middle panel) or presence (lower panel) of APV. The
sections were stained against cFos (green channel) and NeuN (red
channel), and the colocalization of both markers was analyzed (merged
channel). b Statistics of the effects of electrical stimulation and drug
treatment on cFos expression in the CA1 neuronal population stained
with NeuN. Slices were basally stimulated (0.1 Hz) (gray), or E-S
potentiation was induced with HFS (4 × 100 Hz) in the absence (LTP)
(black) or presence of the NMDAR antagonist APVapplied before or 15
and 30 min after HFS. c Exemplary immunofluorescence images of CA1
sections following the induction of synaptic LTPNMDA (see Fig. 2).
Basally stimulated slices (0.1 Hz) (upper panels) were compared with
slices that were fixed 90 min post-LTPNMDA induction with HFS in the
absence (middle panel) or presence (lower panel) of the MMP-3 inhibitor
NNGH. See a for channel description. d Statistics of the effects of
electrical stimulation and NNGH treatment on cFos expression in CA1
neurons following recordings of synaptic NMDAR-mediated responses
(shown in Fig 2). Slices were basally stimulated (0.1 Hz) (gray), or
LTPNMDA was induced with HFS (4 × 100 Hz) in the absence (LTP)
(black) or presence of the MMP-3 inhibitor NNGH applied before or 15
and 30 min after HFS. The numbers on the graphs refer to the number of
sections analyzed. *p < 0.05 vs. basally stimulated slices
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membranes was observed 30 min following passive avoid-
ance training [30], and upregulation of the GluN1 and
GluN2A NMDAR subunits was observed in reach training
[31] and open field exploration [22].
The temporal requirement for NMDAR activity in E-S
plasticity largely overlapped with the requirement for MMP-
3 activity (Fig. 1). Additionally, we and others previously
found that broad MMP inhibition or inhibition of MMP-9 in
Fig. 4 Recombinant MMP-3 promotes NMDAR-mediated responses
and somatodendritic Ca2+ waves following multiple exposures to
NMDA. a Recording scheme for glutamate-evoked NMDAR responses
in acute hippocampal brain slice in the presence of inhibitor cocktail and
Mg2+-free aCSF. A recording (REC) electrode recorded NMDAR-
mediated field potentials in the CA1 stratum radiatum in response to
local pressure injection of glutamate. b Representative NMDAR-
mediated field potentials following short (200 ms) pressure injections of
an external solution that contained the inhibitor cocktail (aCSF) (upper
trace), aCSF + glutamate + D-serine (100 μM) without the NMDAR
antagonist APV (middle trace), or aCSF + glutamate + D-serine with
APV (lower trace). c Time-course of APV-sensitive field potential
amplitude in response to glutamate (every 2 min) in the absence (black
circles) or presence of recombinant MMP-3 (1 μg/ml). Notice the slowly
emerging potentiation of field potential amplitude with time. d, e
Exemplary differential images of relative Fura2 fluorescence change in
somatodendritic compartment (pink) before (d) and during NMDA
application (e, 60 μM; excitation wavelength, 340/380 nm; emission
wavelength, 510 nm). The recording solution was supplemented with a
cocktail of inhibitors to ensure NMDAR activation (see BMaterials and
Methods^ section for details). f Exemplary time-course of Fura2
fluorescence (ΔF340/380) following exogenous application of NMDA
(six applications every 5–6 min) in control neurons (black trace),
neurons incubated with the MMP-3 inhibitor NNGH (10 μM) (gray
trace), and neurons pretreated with recombinant MMP-3 (1 μg/ml) for
30 min before recordings (red trace). Notice that MMP-3 pretreatment
typically enhanced the amplitude of NMDA-evoked Ca2+ waves,
whereas MMP-3 inhibition reduced the amplitude of NMDA-evoked
Ca2+ waves. g Statistics of data shown in f for all KCl-sensitive cells.
The cells were classified as undergoing potentiation (>105 %) (green), no
change (95 > 105%) (yellow), or depression (<95 %) (brown) of NMDA-
evoked Ca2+ wave amplitudes compared with first NMDA application.
Notice that pretreatment with recombinant MMP-3 (n = 171 neurons,
n = 3 cultures) (middle panel) increased the fraction of neurons that
underwent Ca2+ wave amplitude potentiation with time (CTR, n = 408
neurons, n = 5 cultures; χ2: p < 0.001, sixth vs. first) (upper panel). The
MMP-3 inhibitor NNGH had the opposite effect (n = 395 neurons, n = 4
cultures) (lower panel). *p < 0.05 vs. control slices (sixth to first). n
number of slices. *p < 0.05 vs. control slices
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particular had no effect on synaptic LTP when performed ap-
proximately 30 min post-HFS [32–34]. If MMP-3 functions
upstream of NMDAR in our system, then this would require
the rapid release and sustained availability of MMP-3 for 15–
30 min post-HFS. This is plausible because the immunoreac-
tivity of MMP-9 and MMP-3 proteins and expression of
MMP-9 and MMP-3 mRNA transcripts were previously ob-
served in neuronal dendrites [35, 36]. Moreover, MMP-9 was
shown to be rapidly (within a few minutes) and locally trans-
lated following neuronal activity [37].
MMP-3Activity Promotes NMDAR-Mediated Ca2+ Entry
and cFos Expression
Based on the results presented in Figs. 2 and 4, we propose
that MMP-3 may promote E-S plasticity by modulating
NMDAR function and NMDAR-mediated Ca2+ influx, which
may reveal a possible link between extracellularMMP activity
and neuronal plasticity. Notably, both synaptic plasticity and
the plasticity of endogenous excitability require a rise in Ca2+
[7]. With regard to neuronal excitability, NMDAR-mediated
Ca2+ flow affects the activity of calcium-calmodulin kinase II
(CaMKII) and protein synthesis that is crucial for the LTP of
intrinsic excitability [38, 39]. NMDAR-mediated Ca2+ flux
regulates hyperpolarization-activated cationic current (Ih),
which is crucial for dendritic excitability and the magnitude
of E-S potentiation [26, 27]. Moreover, the extent of
NMDAR-mediated membrane depolarization is expected to
determine the rate of the subsequent activity of voltage-
gated conductances and effectiveness of synaptic summation.
Thus, the bursting activity of pyramidal cells is affected by at
least two functionally opposite processes. While Ca2+ influx
promotes membrane depolarization, it also enhances outward
K+ currents via Ca2+-dependent potassium channels. The out-
come of this current interplay determines the occurrence and
duration of bursts in pyramidal neurons [40].
The long-term maintenance of memory traces requires a
rise in Ca2+ and the transcription of pro-plasticity genes [41].
Therefore, we were interested in the extent to which
NMDARs and MMP-3 activity may affect the level of activa-
tion of intracellular pathways that are critical for LTP in our
system.We analyzed the expression of cFos protein, a product
of the IEG c-fos (Fig. 3), because its induction was previously
largely ascribed to NMDAR-mediated Ca2+ flux [42]. cFos
expression was previously investigated to evaluate the activa-
tion of intracellular activity-triggered pathways and found to
be important for experience-dependent neuronal development
and plasticity [43, 44]. In the present study, the magnitude of
E-S potentiation following the manipulation of NMDAR or
MMP-3 activity correlated with cFos expression, suggesting a
correlation with the level of activation of intracellular cascades
that converge on gene transcription (Figs. 1 and 3). cFos in-
duction was mainly triggered by NMDAR-mediated Ca2+
entry, demonstrated by the finding that we blocked L-type
voltage-gated channel activity with nifedipine. Moreover,
the washout of Mg2+ to promote NMDAR activation upregu-
lated the basal proportion of neurons that expressed cFos fol-
lowing HFS (Fig. 3c, d). However, in addition to Ca2+ ions,
several other molecules (e.g., brain-derived neurotrophic fac-
tor [BDNF]), have been implicated in triggering cFos expres-
sion (for review, see [23]). Additionally, E-S potentiation was
affected by APV application for 30 min, but cFos expression
was not (Figs. 2 and 3). This result can be explained by the fact
that although NMDARs remain crucial for IEG expression,
the latter may be additionally altered by the activity of non-
NMDAR ionotropic and metabotropic receptors. Thus, we
cannot exclude the possibility that HFS activated other path-
ways that are important for cFos expression. Finally, the AP1
transcription factor binding site is present in the promoter
region of many MMP genes [45, 46], and the overexpression
of cFos-containing AP-1 dimers induced MMP-9 transcrip-
tion in neurons [47]. Thus, we speculate that the downregula-
tion of MMP-3 activity might additionally suppress long-term
E-S plasticity by negatively impacting the expression of pro-
plasticity proteins and other MMPs. Matrix metalloproteases
cleave proBDNF into mature BDNF, which can occur not
only through the regulation of NMDAR Ca2+ flux but also
through the proteolysis of extracellular factors [47, 48].
MMP Subtype-Specific Modulation of E-S Plasticity
and LTPNMDA
We recently reported that MMP-3 and MMP-2/9 activity re-
mains crucial for E-S plasticity in the CA3 hippocampal cir-
cuit, but the effects of inhibiting these MMPs on the time-
course of E-S LTP were clearly different [17]. The present
results support the view that neuronal plasticity is expressed
in neuronal compartments that are differentially sensitive to
MMP. The MMP-3 inhibitor NNGH abolished CA1 synaptic
LTP (Fig. 1, see also [14]) but the potentiation of PS amplitude
was not completely abolished by this drug (Fig. 1e). This may
suggest that MMP-3 functions mainly in the perisynaptic
space rather than in the somatic space (as shown for MMP-
9; [49]). Alternatively, because PS potentiation relies on
excitation/inhibition balance [10], local changes in
GABAergic inhibition following HFS may have more of an
impact on PS plasticity than on fEPSP plasticity. This issue
will require further investigation.
Several MMP subtypes were previously implicated in the
interaction with NMDARs in vitro. Notably, MMP-7 but not
MMP-1 or MMP-9 was shown to cleave the NR1 subunit of
NMDARs and reduce NMDA-induced Ca2+ waves in acute
brain slices [50]. Additionally, MMP-3 or MMP-7 cleaved
NR1 and NR2A NMDAR subunits in vitro [50, 51]. MMP-
9 also reversibly altered the kinetics of NMDAR-mediated
currents [52] and promoted the lateral diffusion of these
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receptors in vitro [19]. The present study provides additional
functional data by indicating that MMP-3 rather thanMMP-2/
9 activity may promote NMDAR function and NMDAR-
mediated Ca2+ entry in vitro (Figs. 2 and 4). The latter finding
corroborates a recent study in which broad MMP activity was
implicated in supporting NMDA-stimulated Ca2+ waves in
striatal dopaminergic medium spiny neurons [53]. MMP-3-
mediated proteolysis may regulate the activity of other prote-
ases, including MMP-9 and MMP-13 [54], emphasizing the
importance of MMP-3 activity in NMDAR-dependent types
of neural plasticity, learning, and memory [11, 12, 17].
Whether MMP-3 regulates NMDAR function directly or
indirectly remains unknown. The ability of some MMP sub-
types to cleave NMDAR subunits may suggest a direct inter-
action between MMPs and NMDARs [50, 51]. However, an
equally likely possibility is that MMP-3 may indirectly upreg-
ulate NMDARs via protein kinase C and non-receptor tyro-
sine kinase Src activity that mediate LTPNMDA [28]. This
could be achieved by activating such transmembrane proteins
as integrins and intracellular adhesion molecule-5 and also
protease-activated receptor 1, which were previously shown
downstream MMP activity and to affect Src and PKC activity
[14, 32, 55, 56]. The involvement of integrin signaling is
particularly likely because the MMP-3 cleavage of laminin/
fibronectin [54] may provide integrin-activating peptides that
contain the RGD motif. The integrin-blocking peptide
GRGDSP was utilized to compete with the recognition site
for a subclass of integrins that act as fibrinogen receptors, and
GRGDSP prevented HFS-induced LTPNMDA in our system
(Fig. 2(b)). Additionally, integrin interaction with synthetic
RGD peptides was shown to induce LTPNMDA [56] and rapid
Ca2+ waves [57] and interfere with synaptic LTPAMPA up to
15 min post-LTP induction [58], similar to the effects of
NNGH on E-S potentiation in the present study (Fig. 1).
Future studies of isolated synaptic components (e.g., the
NMDA component) may help narrow the list of potential
signaling cascades that are activated by MMP.
Several aspects of the MMP/NMDAR interaction need fur-
ther investigation. We used commercial MMP subtype-
specific inhibitors. However, as discussed previously [11,
17], these drugs at high doses may act as broad-spectrum
inhibitors. In the present study, NNGH (10 μM) application
resulted in fEPSPNMDA depression following HFS, and
UK356618 (2 μM) resulted in a less pronounced effect, sug-
gesting dose-dependent effects of these drugs or differences in
MMP subtype specificity (Fig. 2). Thus, although we used
two different MMP-3 inhibitors and recombinant MMP-3,
we cannot exclude the possibility that other MMPs with sim-
ilar substrate specificity to MMP-3 may play equally impor-
tant roles in E-S potentiation. Another important issue is
whether the MMP-3/NMDAR interaction is subunit-specific.
The NR2A and NR2B subunits of NMDARs conduct signif-
icantly different amounts of Ca2+ [59]. Moreover, different
pools of NMDARs are capable of causing distinct changes
in gene transcription [60]. NMDAR activity has also been
shown to be crucial in long-term associative memory in sev-
eral learning paradigms [61]. Rapid hippocampal place fields
formation [61] and the stability of CA1 spatial maps require
the temporally matched activity of NMDARs [62]. Thus, the
effects of MMP on NMDARs following patterned neuronal
activity in the hippocampal CA1 region may alter the forma-
tion of place fields, which could explain the impairment in
hippocampal spatial learning following MMP inhibition
[63]. Additionally, NMDARs and MMP activity have been
implicated in several neurological and psychiatric disorders,
such as ischemia, epilepsy, schizophrenia, drug addiction, and
neurodegenerative diseases [3, 64]. Particularly important,
MMP-3 activity has been implicated in the pathophysiology
of Parkinson’s disease, Alzheimer’s disease, and ischemic
neuronal death [65]. Therefore, one possibility is that the cou-
pling of MMP-3 and NMDAR activity that was found in the
present study may operate beyond E-S plasticity.
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